Here we reviewed the current knowledge of CEBPA mutation, co-mutation, and the recent advances and recognition of the favorable outcome of bZIP-mutation and its incorporation to the WHO-5, ICC, and ELN classifications. The gene discussed is CEBPA; the disease is intrahepatic cholangiocarcinoma.